Oncology Today with Dr Neil Love
Dr. Neil Love
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
Episodes
Mentioned books
Dec 8, 2025 • 1h 28min
Breast Cancer — Highlights from the 2025 ESMO Annual Meeting
Prof Giuseppe Curigliano from the European Institute of Oncology in Milan, Italy, and Dr Priyanka Sharma from the University of Kansas Cancer Center in Westwood, Kansas, discuss the implications of clinical findings in breast cancer recently presented at the 2025 ESMO Annual Meeting. CME information and select publications here.
Dec 5, 2025 • 15min
Breast Cancer — Microlearning Activity Issue 3 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates
Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, summarizes the treatment landscape for patients with breast cancer and discusses the implications of recently presented clinical findings from the ESMO Congress 2025. CME information and select publications here.
Dec 3, 2025 • 52min
Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning
Dr Matthew Lunning from the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska, discusses recent updates on the management of toxicities associated with CAR T-cell therapy. CME information and select publications here.
Dec 2, 2025 • 17min
Breast Cancer — Microlearning Activity 2 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates
Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, summarizes the treatment landscape for patients with breast cancer and discusses the implications of recently presented clinical findings from the ESMO Congress 2025. CME information and select publications here.
7 snips
Nov 29, 2025 • 59min
Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2
Dr. Rinath M Jeselsohn, a specialist in endocrine therapy resistance at Dana-Farber, and Dr. Joyce O’Shaughnessy, known for her expertise in breast cancer trials, dive into the latest in metastatic breast cancer treatments. They discuss the efficacy of oral selective estrogen receptor degraders, the importance of ctDNA testing for ESR1 mutations, and choices for therapy post-CDK4/6 progression. Insights into combination therapies and recent trial results illuminate the complexities of treatment strategies, providing a comprehensive overview for clinicians.
Nov 26, 2025 • 13min
Breast Cancer — Microlearning Activity 1 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates
Dr. Priyanka Sharma, a medical oncologist from The University of Kansas Cancer Center, delves into the latest breast cancer treatment innovations. She highlights promising results from the Destiny Breast 05 study, showcasing a significant reduction in disease events with TDXD. Discussions include the safety concerns of pneumonitis, the impact of new therapies on brain metastasis, and insights from ongoing trials like COMPASS HER2-RD. Sharma emphasizes the importance of quality-of-life considerations and future maintenance strategies for patients.
Nov 21, 2025 • 58min
HER2-Positive Gastrointestinal Cancers — Clinical Investigator Perspectives on Actual Patient Cases
Dr Tanios Bekaii-Saab and Dr Kristen K Ciombor summarize the treatment landscape and review key datasets in consideration of HER2-directed therapies for patients with HER2-positive gastrointestinal cancers. CME information and select publications here.
Nov 19, 2025 • 59min
HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders
Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, reviews available clinical data with PROTAC estrogen receptor degraders and their potential role in the management of HR-positive metastatic breast cancer. CME information and select publications here.
Nov 15, 2025 • 60min
Patient Education Resource: Non-Hodgkin Lymphoma — Clinical Experts Address Common Questions Posed by Patients About CAR T-Cell Therapy
Dr Jeremy S Abramson from Massachusetts General Hospital in Boston and Dr Manali Kamdar from the University of Colorado Cancer Center in Aurora discuss patient questions and experiences with CAR T-cell therapy for non-Hodgkin lymphoma. Educational information and select publications here.
Nov 14, 2025 • 2h 31min
ER-Positive Metastatic Breast Cancer — A Roundtable Discussion on the Current and Future Role of Oral SERDs
Prof Francois-Clement Bidard from the Institut Curie in Paris, France, Dr Hope S Rugo from the City of Hope Comprehensive Cancer Center in Duarte, California, Dr Rebecca Shatsky from the University of California San Diego Moores Cancer Center and Dr Seth Wander from Massachusetts General Hospital in Boston discuss recent updates on available and emerging treatment strategies involving oral SERDs for ER-positive metastatic breast cancer. CME information and select publications here.
